Pregabalin Completed Phase 3 Trials for Postherpetic Neuralgia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00394901A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
NCT00424372A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia